Perrigo Company plc
HealthcareNYSE:PRGO · New York Stock Exchange
+$0.09 today
Vol 2.50M · Avg 3.05M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
ROE
-48.6%
avg -10.8%
ROIC
4.5%
avg 0.2%
ROA
-16.7%
avg -4.2%
Analysis
ROIC is currently the strongest return metric at 4.5% versus its period average of 0.2%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Patrick Lockwood-Taylor | President, Chief Executive Officer & Director | $2.05M | — | 57 | $136,076.00 | 0.10% |
Abbie Lennox | Executive Vice President & Chief Scientific Officer | $1.69M | — | 45 | $6,603.00 | <0.01% |
Eduardo Guarita Bezerra | Executive Vice President & Chief Financial Officer | $1.13M | — | 50 | $86,935.00 | 0.06% |
Charles Atkinson | Executive Vice President, General Counsel & Secretary | $1.05M | — | 49 | $13,379.00 | <0.01% |
Roberto Khoury | Executive Vice President & Chief Commercial Officer | $988,533.00 | — | 45 | $17,433.00 | 0.01% |
David Ball | EVP and Chief Brand & Digital Officer | — | — | 46 | $7,784.00 | <0.01% |
Eric S. Jacobson | Vice President of Global Investor Relations | — | — | — | — | — |
Robert Willis | Chief Human Resources Officer & Executive Vice President | — | — | 57 | $6,880.00 | <0.01% |
Bradley Joseph | Vice President of Global Investor Relations & Corporate Communications | — | — | — | $44,958.15 | 0.03% |
Matthew Winterman | Executive Vice President of Product Supply, Operations Strategy & Transformation Officer | — | — | 55 | $22,388.00 | 0.02% |
Sonia Hollies | Senior VP & Treasurer | — | — | — | — | — |
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
10
$562,500.03
Sells
0
$0.00
Net Sentiment
+$562,500.03
Net buying
Most Active
Parker Geoffrey M.
3 transactions
Analysis
Insiders reported 10 buys worth $562,500.03 and 0 sells worth $0.00 over the last 12 months. That adds up to net buying of $562,500.03. Parker Geoffrey M. was the most active insider with 3 transactions.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | -40.3% | +8.0% (15yr)1 analysts |
| Revenue | N/A | N/A | +13.2% | -0.7% (15yr)1 analysts |
| Net Income | N/A | N/A | -31.7% | +7.9% (15yr)1 analysts |
| EBIT | N/A | N/A | +9.5% | N/A1 analysts |
Analysis
Recent growth has been strongest in Revenue at +13.2% over three years. Forward estimates point to EPS at +8.0% (15yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Peer companies in the same sector
Scholar Rock Holding Corporation
NASDAQ:SRRK
$5.29B
Amicus Therapeutics, Inc.
FOLD
$4.55B
LivaNova PLC
NASDAQ:LIVN
$4.36B
Heartflow, Inc. Common Stock
NASDAQ:HTFL
$2.87B
Tarsus Pharmaceuticals, Inc.
NASDAQ:TARS
$2.67B
Supernus Pharmaceuticals, Inc.
NASDAQ:SUPN
$2.58B
Surgery Partners, Inc.
NASDAQ:SGRY
$2.00B
HUTCHMED (China) Limited
NASDAQ:HCM
$1.91B
Bausch Health Companies Inc.
NYSE:BHC
$1.89B
Alphatec Holdings, Inc.
NASDAQ:ATEC
$1.27B
Who manages PRGO?
Perrigo Company plc (PRGO) lists 11 active executives. The top listed executive is Abbie Lennox, Executive Vice President & Chief Scientific Officer.
Are PRGO insiders buying or selling?
Recent insider activity shows net buying of $4.48M.
Explore More
Continue the stock analysis
Jump to another research area for this company.